{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:42:13Z","timestamp":1793295733695,"version":"4.5.0"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.phrs.2024.107571","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T03:10:56Z","timestamp":1736046656000},"page":"107571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases"],"prefix":"10.1016","volume":"212","author":[{"given":"Mingyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1671-8140","authenticated-orcid":false,"given":"Weihua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107571_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib3","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China","volume":"165","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2024.107571_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ejmech.2012.12.062","article-title":"Recent advances in natural products from plants for treatment of liver diseases","volume":"63","author":"Zhang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107571_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11655-019-3046-2","article-title":"Current status and problem-solving strategies for ginseng industry","volume":"25","author":"Li","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107327","article-title":"Hepatoprotection by ginsenoside Rg1 in alcoholic liver disease","volume":"92","author":"Yang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1142\/S0192415X23500507","article-title":"Pharmacological effects of ginseng: multiple constituents and multiple actions on humans","volume":"51","author":"Zhou","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cnur.2020.10.011","article-title":"Traditional and current use of ginseng","volume":"56","author":"Flagg","year":"2021","journal-title":"Nurs. Clin. North Am."},{"key":"10.1016\/j.phrs.2024.107571_bib10","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/ptr.8229","article-title":"Saponin monomers: potential candidates for the treatment of type 2 diabetes mellitus and its complications","volume":"38","author":"Zhang","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41401-022-01022-1","article-title":"Ginsenoside Rg1 in neurological diseases: from bench to bedside","volume":"44","author":"Yang","year":"2023","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2024.107571_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110915","article-title":"Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: pharmacology and mechanisms","volume":"132","author":"Fan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107571_bib13","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15977","article-title":"Progress in the mechanism of autophagy and traditional Chinese medicine herb involved in alcohol-related liver disease","volume":"11","author":"Han","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2024.107571_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jgr.2023.11.003","article-title":"Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"Yi","year":"2024","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.phrs.2024.107571_bib15","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.2174\/1389557521666210405160658","article-title":"Mechanism of natural drugs on nonalcoholic fatty liver disease","volume":"21","author":"Xie","year":"2021","journal-title":"MRMC"},{"key":"10.1016\/j.phrs.2024.107571_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13020-020-00400-3","article-title":"Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease","volume":"15","author":"Liu","year":"2020","journal-title":"Chin. Med"},{"key":"10.1016\/j.phrs.2024.107571_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173578","article-title":"A comprehensive review of natural products to fight liver fibrosis: alkaloids, terpenoids, glycosides, coumarins and other compounds","volume":"888","author":"Ma","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1184774","article-title":"The effect of ginsenosides on liver injury in preclinical studies: a systematic review and meta-analysis","volume":"14","author":"Bian","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113999","article-title":"Exploration of tissue distribution of ginsenoside Rg1 by LC-MS\/MS and nanospray desorption electrospray ionization mass spectrometry","volume":"198","author":"Wei","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phrs.2024.107571_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7514802","article-title":"Ginsenoside Rg1 ameliorates palmitic acid-induced hepatic steatosis and inflammation in HepG2 Cells via the AMPK\/NF- \u03ba B pathway","volume":"2019","author":"Xiao","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.phrs.2024.107571_bib21","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1021\/acsomega.0c00529","article-title":"Ginsenoside Rg1 regulates liver lipid factor metabolism in NAFLD model rats","volume":"5","author":"Hou","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.phrs.2024.107571_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107203","article-title":"Multi-layered effects of Panax notoginseng on immune system","volume":"204","author":"Yang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib23","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.1039\/D3FO02580B","article-title":"The anti-aging mechanism of ginsenosides with medicine and food homology","volume":"14","author":"Tian","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2024.107571_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.922029","article-title":"Ginsenosides: allies of gastrointestinal tumor immunotherapy","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113207","article-title":"New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer\u2019s disease","volume":"152","author":"Wu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107571_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1142\/S0192415X06004508","article-title":"Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats","volume":"34","author":"Liu","year":"2006","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116927","article-title":"Chinese herbal medicines: the modulator of nonalcoholic fatty liver disease targeting oxidative stress","volume":"318","author":"Gong","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5487\/TR.2013.29.4.285","article-title":"Subacute oral toxicity study of Korean red ginseng extract in sprague-dawley rats","volume":"29","author":"Park","year":"2013","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib29","unstructured":"F.G. Hess, R.A. Parent, G.E. Coxt, Reproduction study in rats of ginseng extract Gl15, (n.d.)."},{"key":"10.1016\/j.phrs.2024.107571_bib30","unstructured":"R.A. Parent, K.R. Stevens, G.E. Cox, Effects of subchronic feeding of ginseng extract gll5 in beagle dogs, (n.d.).."},{"key":"10.1016\/j.phrs.2024.107571_bib31","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.2147\/IJN.S139602","article-title":"Ginsenoside Rg1 nanoparticle penetrating the blood\u2013brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction","volume":"12","author":"Shen","year":"2017","journal-title":"IJN"},{"key":"10.1016\/j.phrs.2024.107571_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1745-7254.2006.00303.x","article-title":"Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models","volume":"27","author":"Han","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2024.107571_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-2006-957938","article-title":"Main ginseng saponin metabolites formed by intestinal bacteria","volume":"62","author":"Hasegawa","year":"1996","journal-title":"Planta Med"},{"key":"10.1016\/j.phrs.2024.107571_bib34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/np070053v","article-title":"Microbial transformation of 20( S)-protopanaxatriol-type saponins by absidia coerulea","volume":"70","author":"Chen","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2024.107571_bib35","unstructured":"L. Feng, L. Wang, C. Hu, X. Jiang, Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Ginsenoside Rg1 in Rats, (n.d.)."},{"key":"10.1016\/j.phrs.2024.107571_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03190630","article-title":"Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine","volume":"30","author":"Liang","year":"2005","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phrs.2024.107571_bib37","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1124\/dmd.109.029819","article-title":"Absorption and disposition of ginsenosides after oral administration of panax notoginseng extract to rats","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2024.107571_bib38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1089\/jmf.2017.3922","article-title":"Influence of B-complex vitamins on the pharmacokinetics of ginsenosides Rg 1, Rb 1, and Ro after oral administration","volume":"20","author":"Zheng","year":"2017","journal-title":"J. Med. Food"},{"key":"10.1016\/j.phrs.2024.107571_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4793","article-title":"Pharmacokinetic effects of ginsenoside Rg1 on aconitine, benzoylaconine and aconine by UHPLC\u2013MS\/MS","volume":"34","author":"Xu","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.phrs.2024.107571_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-8741(02)00317-3","article-title":"Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats","volume":"84","author":"Xu","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1211\/jpp.61.03.0009","article-title":"Enhancement by adrenaline of ginsenoside Rg1 transport in Caco-2 cells and oral absorption in rats","volume":"61","author":"Xiong","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1211\/jpp.61.03.0014","article-title":"Active absorption of ginsenoside Rg1 in vitro and in vivo: the role of sodium-dependent glucose co-transporter 1","volume":"61","author":"Xiong","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib43","first-page":"153","article-title":"The effects of borneol on the pharmacokinetics and brain distribution of tanshinone IIA, salvianolic acid B and ginsenoside Rg1 in Fufang Danshen preparation in rats","volume":"19","author":"Zhang","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.fitote.2013.04.006","article-title":"Systematic review of recent advances in pharmacokinetics of four classical Chinese medicines used for the treatment of cerebrovascular disease","volume":"88","author":"Zeng","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phrs.2024.107571_bib45","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.21037\/tcr-23-1487","article-title":"Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma","volume":"12","author":"Tan","year":"2023","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107571_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jps.2600720432","article-title":"Effect of ethyl cellulose in a medium-chain triglyceride on the bioavailability of ceftizoxime","volume":"72","author":"Ueda","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03639040701508292","article-title":"The use of lipid-based formulations to increase the oral bioavailability of panax notoginseng saponins following a single oral gavage to rats","volume":"34","author":"Xiong","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.phrs.2024.107571_bib48","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.2147\/IJN.S32385","article-title":"Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia\/reperfusion injury and acute myocardial ischemia in rats","author":"Zhang","year":"2012","journal-title":"IJN"},{"key":"10.1016\/j.phrs.2024.107571_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113468","article-title":"A erythrocyte-platelet hybrid membrane coated biomimetic nanosystem based on ginsenosides and PFH combined with ultrasound for targeted delivery in thrombus therapy","volume":"229","author":"Yang","year":"2023","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.phrs.2024.107571_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative stress injury in doxorubicin-induced cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2024.107571_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2019.01.032","article-title":"Oxidized phospholipids in doxorubicin-induced cardiotoxicity","volume":"303","author":"Koleini","year":"2019","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.phrs.2024.107571_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109547","article-title":"Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling","volume":"122","author":"Qi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107571_bib53","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/nnm-2021-0329","article-title":"Doxorubicin nanomedicine based on ginsenoside Rg1 with alleviated cardiotoxicity and enhanced antitumor activity","volume":"16","author":"Li","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.phrs.2024.107571_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/cancers12010162","article-title":"Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models","volume":"12","author":"Argenziano","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107571_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicle"},{"key":"10.1016\/j.phrs.2024.107571_bib56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/pharmaceutics16050593","article-title":"Mass production of Rg1-loaded small extracellular vesicles using a 3D bioreactor system for enhanced cardioprotective efficacy of doxorubicin-induced cardiotoxicity","volume":"16","author":"Di","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2024.107571_bib57","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jgr.2022.01.001","article-title":"DK-MGAR101, an extract of adventitious roots of mountain ginseng, improves blood circulation by inhibiting endothelial cell injury, platelet aggregation, and thrombus formation","volume":"46","author":"Seong","year":"2022","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.phrs.2024.107571_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood\u2013brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107571_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/pharmaceutics13020201","article-title":"Microemulsion-based media in nose-to-brain drug delivery","volume":"13","author":"Froelich","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2024.107571_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/03639045.2013.858734","article-title":"Pharmacokinetics and efficiency of brain targeting of ginsenosides Rg1 and Rb1 given as Nao-Qing microemulsion","volume":"41","author":"Li","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.phrs.2024.107571_bib61","first-page":"229","article-title":"Feasibility study of ginsenoside Rg1administrated via intranasal route","volume":"35","author":"Chen","year":"2010","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/21691401.2018.1548471","article-title":"Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment","volume":"47","author":"Shen","year":"2019","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"10.1016\/j.phrs.2024.107571_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123284","article-title":"Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression","volume":"643","author":"Yu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107571_bib64","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.2147\/IJN.S380515","article-title":"Ginsenoside Rg1 nanoparticles induce demethylation of H3K27me3 in VEGF-A and Jagged 1 promoter regions to activate angiogenesis after ischemic stroke","volume":"17","author":"Shang","year":"2022","journal-title":"IJN"},{"key":"10.1016\/j.phrs.2024.107571_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2016.11.015","article-title":"Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsules","volume":"112","author":"Abellan-Pose","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2024.107571_bib66","first-page":"277","article-title":"Atraumatic osteonecrosis of the humeral head: pathophysiology and current concepts of evaluation and treatment","volume":"2","author":"Castillo Mercado","year":"2022","journal-title":"JSES Rev., Rep., Tech."},{"key":"10.1016\/j.phrs.2024.107571_bib67","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.3390\/ijms22126564","article-title":"The influence of strontium on bone tissue metabolism and its application in osteoporosis treatment","volume":"22","author":"Ko\u0142odziejska","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107571_bib68","doi-asserted-by":"crossref","first-page":"1600156","DOI":"10.1002\/mabi.201600156","article-title":"Charpentier, Angiogenic Rg 1 \/Sr-Doped TiO 2 Nanowire\/Poly(Propylene Fumarate) Bone Cement Composites","volume":"17","author":"Salarian","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.phrs.2024.107571_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111622","article-title":"Co-electrospun nano-\/microfibrous composite scaffolds with structural and chemical gradients for bone tissue engineering","volume":"119","author":"Luo","year":"2021","journal-title":"Mater. Sci. Eng.: C."},{"key":"10.1016\/j.phrs.2024.107571_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12951-023-01787-5","article-title":"All-in-one smart dressing for simultaneous angiogenesis and neural regeneration","volume":"21","author":"Yuan","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107571_bib71","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.biomaterials.2013.05.005","article-title":"A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing","volume":"34","author":"Gong","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107571_bib72","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1016\/j.biomaterials.2010.03.064","article-title":"Cell-laden microengineered gelatin methacrylate hydrogels","volume":"31","author":"Nichol","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107571_bib73","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.phrs.2024.107571_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jep.2015.07.020","article-title":"Anti-inflammatory function of ginsenoside Rg1 on alcoholic hepatitis through glucocorticoid receptor related nuclear factor-kappa B pathway","volume":"173","author":"Gao","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib76","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","article-title":"Microbiome as a therapeutic target in alcohol-related liver disease","volume":"70","author":"Sarin","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2020.07.004","article-title":"Microbiota reprogramming for treatment of alcohol-related liver disease","volume":"226","author":"Siddiqui","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib78","first-page":"1","article-title":"Hepatoprotective mechanism of ginsenoside rg1 against alcoholic liver damage based on gut microbiota and network pharmacology","volume":"2022","author":"Xia","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2024.107571_bib79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut\u2013liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2024.107571_bib80","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.3390\/ijms24043735","article-title":"Alcohol, inflammation, and microbiota in alcoholic liver disease","volume":"24","author":"Duki\u0107","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107571_bib81","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2017.3297","article-title":"Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor\u2011\u03baB pathway and inhibition of inflammasome activation in alcoholic hepatitis","author":"Li","year":"2017","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.phrs.2024.107571_bib82","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.jceh.2022.05.004","article-title":"Pathogenesis of alcohol-associated liver disease","volume":"12","author":"Osna","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.toxlet.2008.12.006","article-title":"Ethanol-induced expression of glutamate\u2013cysteine ligase catalytic subunit gene is mediated by NF-\u03baB","volume":"185","author":"Kimura","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2024.107571_bib84","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/aps.2014.41","article-title":"Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis","volume":"35","author":"Li","year":"2014","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2024.107571_bib85","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/10286020.2016.1162787","article-title":"Rg1 Attenuates alcoholic hepatic damage through regulating AMP-activated protein kinase and nuclear factor erythroid 2-related factor 2 signal pathways","volume":"18","author":"Gao","year":"2016","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2024.107571_bib87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7150\/ijbs.87305","article-title":"The role of nuclear receptors in the pathogenesis and treatment of non-alcoholic fatty liver disease","volume":"20","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib88","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib90","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107571_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117776","article-title":"Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor","volume":"254","author":"Qi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib92","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic Inflammation and Insulin Resistance in Obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2024.107571_bib94","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","article-title":"Hypertension in diabetes: an update of basic mechanisms and clinical disease","volume":"78","author":"Jia","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2024.107571_bib95","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2019.04.027","article-title":"Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation","volume":"854","author":"Fan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib96","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.pharep.2019.07.004","article-title":"Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity","volume":"71","author":"Mo","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2024.107571_bib97","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3892\/mmr.2022.12694","article-title":"Ginsenoside Rg1 exerts anti\u2011apoptotic effects on non\u2011alcoholic fatty liver cells by downregulating the expression of SGPL1","volume":"25","author":"Li","year":"2022","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.phrs.2024.107571_bib98","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.drudis.2007.07.009","article-title":"Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Ahmed","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2024.107571_bib99","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1080\/09168451.2020.1793293","article-title":"Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid","volume":"84","author":"Gao","year":"2020","journal-title":"Biosci., Biotechnol., Biochem."},{"key":"10.1016\/j.phrs.2024.107571_bib100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hepres.2005.09.020","article-title":"Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases","volume":"33","author":"Seki","year":"2005","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"\u00d6zcan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107571_bib102","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1248\/bpb.b18-00132","article-title":"Ginsenoside Rg1 Protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation","volume":"41","author":"Xu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2024.107571_bib103","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/oby.23250","article-title":"Preparing for the NASH epidemic: A call to action","volume":"29","author":"Kanwal","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.phrs.2024.107571_bib104","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2024.107571_bib105","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.3390\/ijms23147734","article-title":"Cell autophagy in NASH and NASH-related hepatocellular carcinoma","volume":"23","author":"Udoh","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107571_bib106","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41419-018-1004-0","article-title":"Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway","volume":"9","author":"Qiu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107571_bib107","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-023-01787-2","article-title":"Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p\/ATG2B\/PTEN-AKT axis to mediate autophagy and pyroptosis","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2024.107571_bib108","article-title":"Inflammation aggravated the hepatotoxicity of triptolide by oxidative stress, lipid metabolism disorder, autophagy, and apoptosis in zebrafish","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib109","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107571_bib110","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1111\/jcmm.16376","article-title":"Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN\/PI3K\/AKT pathway","volume":"25","author":"Riaz","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2017.06.190","article-title":"BCL-2 proteins and apoptosis: Recent insights and unknowns","volume":"500","author":"Edlich","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107571_bib112","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.30834","article-title":"The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis","volume":"71","author":"Papatheodoridi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107571_bib113","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.livres.2017.11.004","article-title":"FOXO transcription factors in non-alcoholic fatty liver disease","volume":"1","author":"Dong","year":"2017","journal-title":"Liver Res."},{"key":"10.1016\/j.phrs.2024.107571_bib114","doi-asserted-by":"crossref","first-page":"20132","DOI":"10.1074\/jbc.M112.347211","article-title":"FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c","volume":"287","author":"Deng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107571_bib115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2016.03.021","article-title":"Integrated regulation of hepatic lipid and glucose metabolism by adipose triacylglycerol lipase and FoxO proteins","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107571_bib116","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1194\/jlr.M039339","article-title":"Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6","volume":"54","author":"Tao","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2024.107571_bib117","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1074\/jbc.M110.201061","article-title":"Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene","volume":"286","author":"Tao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107571_bib118","doi-asserted-by":"crossref","first-page":"39107","DOI":"10.1074\/jbc.M112.412569","article-title":"The Autophagy-related Gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism","volume":"287","author":"Xiong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107571_bib119","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.cell.2019.07.021","article-title":"LECT2, a Ligand for tie1, plays a crucial role in liver fibrogenesis","volume":"178","author":"Xu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107571_bib120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153294","article-title":"Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-\u03b2\/Smad and YAP signaling","volume":"78","author":"Xiang","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107571_bib122","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3748\/wjg.v26.i21.2810","article-title":"Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation","volume":"26","author":"Du","year":"2020","journal-title":"WJG"},{"key":"10.1016\/j.phrs.2024.107571_bib123","doi-asserted-by":"crossref","first-page":"207","DOI":"10.14218\/JCTH.2021.00101","article-title":"KRT17 promotes the activation of HSCs via EMT in liver fibrosis","volume":"10","author":"Chen","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib124","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1042\/CS20160334","article-title":"Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT","volume":"130","author":"Wu","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib125","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jgr.2022.12.005","article-title":"Ginsenoside Rg1 epigenetically modulates smad7 expression in liver fibrosis via MicroRNA-152","volume":"47","author":"Zhang","year":"2023","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.phrs.2024.107571_bib126","article-title":"Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis","volume":"14","author":"Lyu","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2024.107571_bib127","article-title":"Downregulation of miR\u2011152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro","author":"Li","year":"2019","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.phrs.2024.107571_bib128","unstructured":"Y. Tang, N. Ma, H. Luo, S. Chen, F. Yu, Downregulated long non-coding RNA LINC01093 in liver fibrosis promotes hepatocyte apoptosis via increasing ubiquitination of SIRT, (n.d.)."},{"key":"10.1016\/j.phrs.2024.107571_bib129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41419-020-2575-0","article-title":"Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B\/PDGFR-\u03b2 pathway in hepatic stellate cells","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107571_bib130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2010.02.022","article-title":"Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats","volume":"634","author":"Geng","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/biof.1432","article-title":"Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo","volume":"44","author":"Wei","year":"2018","journal-title":"BioFactors"},{"key":"10.1016\/j.phrs.2024.107571_bib132","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-022-05088-x","article-title":"Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107571_bib133","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0891-5849(00)00396-8","article-title":"The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl4-induced acute liver injury of mice","volume":"29","author":"Zhu","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib134","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fct.2007.08.016","article-title":"Protective effects of Pycnogenol\u00ae on carbon tetrachloride-induced hepatotoxicity in Sprague\u2013Dawley rats","volume":"46","author":"Yang","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2024.107571_bib135","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.7150\/ijbs.92749","article-title":"Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells","volume":"20","author":"Hao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10715762.2016.1234710","article-title":"Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice","volume":"51","author":"Gao","year":"2017","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib137","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jep.2017.04.012","article-title":"Hepataprotective effects of ginsenoside Rg1 \u2013 a review","volume":"206","author":"Gao","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2022.101925","article-title":"Narrative engineering of the liver","volume":"75","author":"Lee","year":"2022","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.phrs.2024.107571_bib139","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.phrs.2024.107571_bib140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib141","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.akdh.2024.03.001","article-title":"Toxin-Induced Liver Injury and extracorporeal treatment of liver failure","volume":"31","author":"Lam","year":"2024","journal-title":"Adv. Kidney Dis. Health"},{"key":"10.1016\/j.phrs.2024.107571_bib142","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/1751-2980.12697","article-title":"Corticosteroid therapy in drug-induced liver injury: Pros and cons","volume":"20","author":"Hu","year":"2019","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.phrs.2024.107571_bib143","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.3390\/ijms242417290","article-title":"Therapeutic applications of ginseng natural compounds for health management","volume":"24","author":"Ahmad","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107571_bib144","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.intimp.2018.08.037","article-title":"Piceatannol attenuates D-GalN\/LPS-induced hepatoxicity in mice: Involvement of ER stress, inflammation and oxidative stress","volume":"64","author":"Wen","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.intimp.2018.06.008","article-title":"Protective effects of ginsenoside Rg1 against lipopolysaccharide\/ d -galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway","volume":"61","author":"Ning","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib146","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib147","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107571_bib148","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2018.6727","article-title":"Ginsenoside Rg1 attenuates liver injury induced by D\u2011galactose in mice","author":"Xiao","year":"2018","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.phrs.2024.107571_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202115764","article-title":"Spatially confined intervention of cellular senescence by a lysosomal metabolism targeting molecular prodrug for broad-spectrum senotherapy","volume":"61","author":"Xia","year":"2022","journal-title":"Angew. Chem. Int Ed."},{"key":"10.1016\/j.phrs.2024.107571_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3085756","article-title":"Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases","volume":"2019","author":"Moldogazieva","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2024.107571_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104438","article-title":"MiR-195 suppression alleviates apoptosis and oxidative stress in CCl4-induced ALI in mice by targeting Pim-1","volume":"115","author":"Yang","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.phrs.2024.107571_bib152","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/tox.22616","article-title":"Hepatoprotective effect of ginsenoside Rg1 from Panax ginseng on carbon tetrachloride-induced acute liver injury by activating Nrf2 signaling pathway in mice","volume":"33","author":"Ning","year":"2018","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.phrs.2024.107571_bib153","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.3892\/mmr.2017.6920","article-title":"Protective effect and mechanism of ginsenoside Rg1 on carbon tetrachloride-induced acute liver injury","volume":"16","author":"Qi","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2024.107571_bib154","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.phymed.2016.02.026","article-title":"Protective effects of Ginsenoside Rg1 against carbon tetrachloride-induced liver injury in mice through suppression of inflammation","volume":"23","author":"Xin","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107571_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib156","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/acs.chemrestox.9b00204","article-title":"Advances in toxicological research of the anticancer drug cisplatin","volume":"32","author":"Qi","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.phrs.2024.107571_bib157","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/brainsci10110847","article-title":"p62-Nrf2-p62 mitophagy regulatory loop as a target for preventive therapy of neurodegenerative diseases","volume":"10","author":"Gureev","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib158","first-page":"1","article-title":"Natural product andrographolide alleviated APAP-induced liver fibrosis by activating Nrf2 antioxidant pathway","author":"Yan","year":"2018","journal-title":"Toxicology 396\u2013397"},{"key":"10.1016\/j.phrs.2024.107571_bib159","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical practice guidelines: drug-induced liver injury","volume":"70","author":"Andrade","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfaa002","article-title":"Novel therapeutic approaches against acetaminophen-induced liver injury and acute liver failure","volume":"174","author":"Jaeschke","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib161","unstructured":"A.M.L. Slitt, P.K. Dominick, J.C. Roberts, S.D. Cohen, Effect of Ribose Cysteine Pretreatment on Hepatic and Renal Acetaminophen Metabolite Formation and Glutathione Depletion, (n.d.)."},{"key":"10.1016\/j.phrs.2024.107571_bib162","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yrtph.2018.07.012","article-title":"Ginsenoside Rg1 protects against acetaminophen-induced liver injury via activating Nrf2 signaling pathway in vivo and in vitro","volume":"98","author":"Ning","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib163","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13816","article-title":"Ginsenoside Rg1 and ginsenoside Rh1 prevent liver injury induced by acetaminophen in mice","volume":"45","author":"Bi","year":"2021","journal-title":"J. Food Biochem"},{"key":"10.1016\/j.phrs.2024.107571_bib164","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1080\/15287390701457662","article-title":"Influence of acetaminophen vehicle on regulation of transporter gene expression during hepatotoxicity","volume":"70","author":"Aleksunes","year":"2007","journal-title":"J. Toxicol. Environ. Health, Part A"},{"key":"10.1016\/j.phrs.2024.107571_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116355","article-title":"Natural products as non-covalent and covalent modulators of the KEAP1\/NRF2 pathway exerting antioxidant effects","volume":"270","author":"Culletta","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107571_bib166","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","article-title":"Review: pathogenesis of cholestatic liver diseases","volume":"12","author":"Yokoda","year":"2020","journal-title":"WJH"},{"key":"10.1016\/j.phrs.2024.107571_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109062","article-title":"Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes","volume":"324","author":"Xiao","year":"2020","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.phrs.2024.107571_bib168","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.3390\/nu14193938","article-title":"Ginsenosides restore lipid and redox homeostasis in mice with intrahepatic cholestasis through SIRT1\/AMPK pathways","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107571_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117089","article-title":"Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation","volume":"319","author":"Gao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113657","article-title":"Targeting Sirtuin 1 signaling pathway by ginsenosides","volume":"268","author":"Lou","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib171","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/hep.30275","article-title":"Fine-tuning of sirtuin 1 expression is essential to protect the liver from cholestatic liver disease","volume":"69","author":"Blokker","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107571_bib172","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3389\/fphar.2018.01428","article-title":"The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Xu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib173","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.etap.2018.04.016","article-title":"Paeonol alleviated acute alcohol-induced liver injury via SIRT1\/Nrf2\/NF-\u03baB signaling pathway","volume":"60","author":"Sun","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib174","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3727\/105221619X15614873062730","article-title":"Inflammation and cell death during cholestasis: the evolving role of bile acids","volume":"19","author":"Woolbright","year":"2019","journal-title":"Gene Expr."},{"key":"10.1016\/j.phrs.2024.107571_bib175","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.3390\/ijms21113858","article-title":"Relevance of SIRT1-NF-\u03baB axis as therapeutic target to ameliorate inflammation in liver disease","volume":"21","author":"De Gregorio","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107571_bib176","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.taap.2017.11.007","article-title":"Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition","volume":"338","author":"Cepa","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib177","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jhbp.537","article-title":"Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1\u03b1","volume":"25","author":"Zhu","year":"2018","journal-title":"J. Hepato Biliary Pancreat."},{"key":"10.1016\/j.phrs.2024.107571_bib178","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2017.11.017","article-title":"Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes","volume":"115","author":"Burban","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib179","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3389\/fimmu.2020.01193","article-title":"Effect of hepatic macrophage polarization and apoptosis on liver ischemia and reperfusion injury during liver transplantation","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107571_bib180","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10753-023-01792-8","article-title":"Chlorogenic acid alleviates hepatic ischemia\u2013reperfusion injury by inhibiting oxidative stress, inflammation, and mitochondria-mediated apoptosis in vivo and in vitro","volume":"46","author":"Li","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2024.107571_bib181","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s12035-023-03787-w","article-title":"Targeting NF-\u03baB in hepatic ischemia\u2013reperfusion alleviation: from signaling networks to therapeutic targeting","volume":"61","author":"Deng","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107571_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22644","article-title":"A bibliometric and visualized analysis of hepatic ischemia-reperfusion injury (HIRI) from 2002 to 2021","volume":"9","author":"Lin","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2024.107571_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110398","article-title":"The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I\/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis","volume":"129","author":"Lin","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107571_bib184","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00018-017-2502-4","article-title":"Mitochondrial permeability transition in cardiac ischemia\u2013reperfusion: whether cyclophilin D is a viable target for cardioprotection?","volume":"74","author":"Javadov","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12031-016-0843-3","article-title":"Prevention of cyclophilin D-mediated mPTP opening using cyclosporine-a alleviates the elevation of necroptosis, autophagy and apoptosis-related markers following global cerebral ischemia-reperfusion","volume":"61","author":"Fakharnia","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2024.107571_bib186","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2014.03.067","article-title":"Ginsenoside Rg1 protects mouse liver against ischemia\u2013reperfusion injury through anti-inflammatory and anti-apoptosis properties","volume":"191","author":"Tao","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.phrs.2024.107571_bib187","first-page":"1","article-title":"Ginsenoside Rg1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice via Activating ER\u03b1-Regulating YAP Expression","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib188","volume":"145","author":"Vollmar","year":"1994","journal-title":"Hepatic Microcirc. Perfus. Fail. Is. a Determinant Liver Dysfunct. Warm. Ischemia-Reperfus."},{"key":"10.1016\/j.phrs.2024.107571_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9610(00)00573-0","article-title":"Hepatic ischemia-reperfusion injury","author":"Serracino-Inglott","year":"2001","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.phrs.2024.107571_bib190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2004.03.022","article-title":"Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury","volume":"41","author":"Caraceni","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib191","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/1566524033479564","article-title":"Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia \/ reperfusion injury to hepatocytes","volume":"3","author":"Kim","year":"2003","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.phrs.2024.107571_bib192","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107571_bib193","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/ars.2013.5486","article-title":"Reactive Oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver","volume":"21","author":"Reiniers","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2024.107571_bib194","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/hep.25802","article-title":"Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway","volume":"57","author":"Ji","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107571_bib195","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.bbrc.2018.07.013","article-title":"The protective effects of estrogen on hepatic ischemia-reperfusion injury in rats by downregulating the Ang II\/AT1R pathway","volume":"503","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107571_bib196","unstructured":"R.Y.K. Chan, W.-F. Chen, A. Dong, D. Guo, M.-S. Wong, Estrogen-Like Activity of Ginsenoside Rg1 Derived from Panax notoginseng, (n.d.)."},{"key":"10.1016\/j.phrs.2024.107571_bib197","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jgr.2018.03.004","article-title":"Ginsenoside Rg1 activates ligand-independent estrogenic effects via rapid estrogen receptor signaling pathway","volume":"43","author":"Gao","year":"2019","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.phrs.2024.107571_bib198","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","article-title":"Acute liver failure","volume":"404","author":"Maiwall","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107571_bib199","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000873","article-title":"The future of liver transplantation","author":"Feng","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107571_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2021.101706","article-title":"Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-\u03baB pathway","volume":"56","author":"Jin","year":"2021","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.phrs.2024.107571_bib201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/538059","article-title":"Ginsenosides Rg1 from panax ginseng: a potential therapy for acute liver failure patients?","volume":"2014","author":"Zhao","year":"2014","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2024.107571_bib202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11010-013-1674-y","article-title":"Ginsenoside Rg1 attenuates concanavalin A-induced hepatitis in mice through inhibition of cytokine secretion and lymphocyte infiltration","volume":"380","author":"Cao","year":"2013","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.phrs.2024.107571_bib203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-023-00461-2","article-title":"Hepatitis A virus infection","volume":"9","author":"Van Damme","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2024.107571_bib204","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3390\/v13101900","article-title":"Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment","volume":"13","author":"Migueres","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.phrs.2024.107571_bib205","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.3390\/ijms23137214","article-title":"Hepatitis A virus infection and molecular research","volume":"23","author":"Kanda","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107571_bib206","doi-asserted-by":"crossref","DOI":"10.1111\/1750-3841.12205","article-title":"Reduction of hepatitis a virus on FRhK-4 cells treated with korean red ginseng extract and ginsenosides","volume":"78","author":"Lee","year":"2013","journal-title":"J. Food Sci."},{"key":"10.1016\/j.phrs.2024.107571_bib207","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jgr.2022.11.003","article-title":"Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action","volume":"47","author":"Zhang","year":"2023","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.phrs.2024.107571_bib208","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2009.03.014","article-title":"Activation of the 2-5OAS\/RNase L pathway in CVB1 or HAV\/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression","volume":"388","author":"Kulka","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.phrs.2024.107571_bib209","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107571_bib210","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7326\/M17-1106","volume":"167","author":"Abara","year":"2017","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.phrs.2024.107571_bib211","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1139\/cjpp-2015-0528","article-title":"Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in mice","volume":"94","author":"Yuan","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107571_bib212","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR Agonists as vaccine adjuvants targeting cancer and infectious diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2024.107571_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102446","article-title":"The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution","volume":"69","author":"O\u2019Neill","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.phrs.2024.107571_bib214","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5582\/bst.2023.01311","article-title":"An update on diagnosis and treatment of hepatoblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"BST"},{"key":"10.1016\/j.phrs.2024.107571_bib215","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/CAD.0000000000000646","article-title":"Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage","volume":"29","author":"Zhen","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.phrs.2024.107571_bib216","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.3390\/molecules24244501","article-title":"Review of ginseng anti-diabetic studies","volume":"24","author":"Chen","year":"2019","journal-title":"Molecules"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824005164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824005164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T17:54:43Z","timestamp":1740246883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824005164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":216,"alternative-id":["S1043661824005164"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107571","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107571"}}